| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2018-05-23 | Celyad (Belgium) | $54.4 million (approximately €46.1 million), | private placement | Cancer - Oncology | Private placement | |
| 2018-05-16 | HiFiBiO Therapeutics (USA - MA) | $37.5 million | series B financing round | Sequoia China (China) LYFE Capital (China) VI Ventures (China) Nest.Bio Ventures (USA - MA) Legend Star Capital (China) Proxima Ventures (Israel) | Technology - Services | Series B financing round |
| 2018-05-09 | IGEM Therapeutics (UK) | £1.45 million | grant | Innovate UK (UK) | Cancer - Oncology | Grant |
| 2018-05-08 | InflaRX (Germany) | $62.9 million | private placement | Inflammatory diseases | Private placement | |
| 2018-05-07 | Melinta Therapeutics (USA - CT) | up to $6.2 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2018-05-03 | Synpromics (UK) | £1.9 million | grant | Scottish Enterprise (UK) | Technology - Services | Grant |
| 2018-04-30 | Sangamo Therapeutics (USA - CA) | $230 million | private placement | Rare diseases - Genetic diseases | Private placement | |
| 2018-04-27 | Sangamo Therapeutics (USA - CA) | $8 million | grant | California Institute for Regenerative Medicine (CIRM) (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases | Grant |
| 2018-04-27 | A-Mansia (Belgium) | €13 million | series A financing round | Seventure (France) Fonds Vives II (Belgium) SRIW Life Sciences (Belgium) Nivelinvest (Belgium) Pierre Drion | Metabolic diseases | Series A financing round |
| 2018-04-26 | Mereo BioPharma (UK) | IPO | Rare diseases - Genetic diseases | IPO | ||
| 2018-04-19 | Tmunity Therapeutics (USA - PA) | $135 million | series A financing round | Kleiner Perkins (USA) Ping An Ventures (China) Parker Institute for Cancer Immunotherapy (USA - CA) Gilead Sciences, (USA - CA) Be The Match BioTherapies (USA - MN) University of Pennsylvania (USA - PA) Lilly Asia Ventures (China) | Cancer - Oncology | Series A financing round |
| 2018-04-02 | ITBMed (Sweden) | up to $67 million | financing round | Royalty Pharma (US - NY) | Transplantation | Financing round |
| 2018-03-27 | Poietis (France) | €5 million | series A financing round, grant | WiSEED (France) Nouvelle Aquitaine Coinvestment Fund (France) | Technology - Services | Series A financing round |
| 2018-03-15 | Ideaya Bioscience (USA - CA) | $94 million | series B financing round | BVF Partners (USA - CA) Perceptive Advisors (USA - NY) 6 Dimensions Capital (China) Tavistock Group (Bahamas) Nextech Invest (Switzerland) GV (USA - CA) Roche Venture Fund (Switzerland) 5AM Ventures (USA - CA) Canaan Partners (USA - CA) Celgene (USA - NJ) WuXi Healthcare Ventures (China) Novartis Institute of Biomedical Research -Alexandria Real Estate | Cancer - Oncology | Series B financing round |
| 2018-02-23 | Fate Therapeutics (USA - CA) | $4 million | grant | California Institute for Regenerative Medicine (CIRM) (USA - CA) | Cancer - Oncology | Grant |
| 2018-02-23 | Fate Therapeutics (USA - CA) | $4 million | grant | California Institute for Regenerative Medicine (CIRM) (USA - CA) | Cancer - Oncology | Grant |
| 2018-02-16 | ABAC Therapeutics (Spain) | €16 million | series A financing round | Pontifax (Israel) Quark Venture (Canada) GF Securities (China) Caixa Capital Risc (Spain) Debiopharm Innovation Fund (Switzerland) Ferrer (Spain) | Infectious diseases | Series A financing round |
| 2018-02-07 | Sangamo Therapeutics (USA - CA) Case Western Research University (USA - OH) | $11 million | grant | National Institutes of Health (NIH) (USA) | Infectious diseases | Grant |
| 2018-02-05 | Metrion Biosciences (UK) | £200 000 | grant | Innovate UK Biomedical Catalyst Feasibility Award scheme (UK) | Autoimmune diseases - Neurodegenerative diseases | Grant |
| 2018-02-02 | Viking Therapeutics (USA - PA) | $55 million | private placement | Endocrinological diseases - Metabolic diseases | Private placement |
